EP1104486A4 - NEW METHOD FOR DIAGNOSING, MONITORING, STADIUM CLASSIFICATION, IMAGING AND TREATING LUNG CANCER - Google Patents
NEW METHOD FOR DIAGNOSING, MONITORING, STADIUM CLASSIFICATION, IMAGING AND TREATING LUNG CANCERInfo
- Publication number
- EP1104486A4 EP1104486A4 EP99935685A EP99935685A EP1104486A4 EP 1104486 A4 EP1104486 A4 EP 1104486A4 EP 99935685 A EP99935685 A EP 99935685A EP 99935685 A EP99935685 A EP 99935685A EP 1104486 A4 EP1104486 A4 EP 1104486A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- diagnosing
- imaging
- monitoring
- lung cancer
- new method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
- A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Radiology & Medical Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Optics & Photonics (AREA)
- Zoology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9523398P | 1998-08-04 | 1998-08-04 | |
| US95233P | 1998-08-04 | ||
| PCT/US1999/016247 WO2000008206A1 (en) | 1998-08-04 | 1999-07-19 | A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1104486A1 EP1104486A1 (en) | 2001-06-06 |
| EP1104486A4 true EP1104486A4 (en) | 2002-07-17 |
Family
ID=22250833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP99935685A Withdrawn EP1104486A4 (en) | 1998-08-04 | 1999-07-19 | NEW METHOD FOR DIAGNOSING, MONITORING, STADIUM CLASSIFICATION, IMAGING AND TREATING LUNG CANCER |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1104486A4 (en) |
| JP (1) | JP3524061B2 (en) |
| CA (1) | CA2347656A1 (en) |
| WO (1) | WO2000008206A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6869592B1 (en) | 1998-08-04 | 2005-03-22 | Diadexus, Inc. | Method and antibody for imaging lung cancer |
| US20030017468A1 (en) * | 2000-08-28 | 2003-01-23 | Sei-Yu Chen | Compositions and methods relating to lung specific genes |
| JP2004520821A (en) * | 2000-10-26 | 2004-07-15 | ディアデクサス インコーポレーテッド | Compositions and methods for lung-specific genes and proteins |
| US20020160388A1 (en) * | 2000-11-20 | 2002-10-31 | Roberto Macina | Compositions and methods relating to lung specific genes and proteins |
| JP2004520831A (en) * | 2000-11-20 | 2004-07-15 | ディアデクサス インコーポレーテッド | Compositions and methods for lung-specific genes and proteins |
| WO2002068633A2 (en) * | 2000-11-22 | 2002-09-06 | Diadexus, Inc. | Compositions and methods relating to lung specific genes and proteins |
| DE10254601A1 (en) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Gene products differentially expressed in tumors and their use |
| DE102004024617A1 (en) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentially expressed in tumors gene products and their use |
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| US7951781B2 (en) | 2006-11-02 | 2011-05-31 | University Of Iowa Research Foundation | Methods and compositions related to PLUNC surfactant polypeptides |
| WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
| WO2014075788A1 (en) | 2012-11-13 | 2014-05-22 | Biontech Ag | Agents for treatment of claudin expressing cancer diseases |
| GB2630774A (en) * | 2023-06-07 | 2024-12-11 | Curenetics Ltd | Lung cancer biomarkers |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0695760A1 (en) * | 1994-08-05 | 1996-02-07 | F. Hoffmann-La Roche Ag | Novel tumor marker for lung cancer |
| US5589579A (en) * | 1994-07-19 | 1996-12-31 | Cytoclonal Pharmaceutics, Inc. | Gene sequence and probe for a marker of non-small cell lung carinoma |
| WO1998020143A1 (en) * | 1996-11-05 | 1998-05-14 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the lung |
| WO1998056951A1 (en) * | 1997-06-11 | 1998-12-17 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the lung |
| WO1999060160A1 (en) * | 1998-05-21 | 1999-11-25 | Diadexus Llc | A novel method of diagnosing, monitoring, and staging lung cancer |
-
1999
- 1999-07-19 WO PCT/US1999/016247 patent/WO2000008206A1/en not_active Ceased
- 1999-07-19 JP JP2000563828A patent/JP3524061B2/en not_active Expired - Fee Related
- 1999-07-19 CA CA002347656A patent/CA2347656A1/en not_active Abandoned
- 1999-07-19 EP EP99935685A patent/EP1104486A4/en not_active Withdrawn
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5589579A (en) * | 1994-07-19 | 1996-12-31 | Cytoclonal Pharmaceutics, Inc. | Gene sequence and probe for a marker of non-small cell lung carinoma |
| EP0695760A1 (en) * | 1994-08-05 | 1996-02-07 | F. Hoffmann-La Roche Ag | Novel tumor marker for lung cancer |
| WO1998020143A1 (en) * | 1996-11-05 | 1998-05-14 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the lung |
| WO1998056951A1 (en) * | 1997-06-11 | 1998-12-17 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the lung |
| WO1999060160A1 (en) * | 1998-05-21 | 1999-11-25 | Diadexus Llc | A novel method of diagnosing, monitoring, and staging lung cancer |
Non-Patent Citations (1)
| Title |
|---|
| See also references of WO0008206A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3524061B2 (en) | 2004-04-26 |
| JP2002522046A (en) | 2002-07-23 |
| WO2000008206A1 (en) | 2000-02-17 |
| EP1104486A1 (en) | 2001-06-06 |
| CA2347656A1 (en) | 2000-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1104486A4 (en) | NEW METHOD FOR DIAGNOSING, MONITORING, STADIUM CLASSIFICATION, IMAGING AND TREATING LUNG CANCER | |
| EP1090291A4 (en) | METHOD OF EARLY DIAGNOSIS OF CANCER AND DETERMINATION OF PROGNOSIS THEREOF | |
| EP1455645A4 (en) | METHOD AND SYSTEM FOR PROCESSING ELECTROCARDIOGRAMS | |
| FR2743642B1 (en) | METHOD AND APPARATUS FOR DIAGNOSING ABNORMALITIES OF A SYSTEM | |
| EP1107798A4 (en) | NEW METHOD FOR DIAGNOSING, MONITORING, STADIUM CLASSIFICATION, IMAGING AND TREATING COLON CANCER | |
| EP1459243A4 (en) | METHOD AND SYSTEM FOR IMAGE ANALYSIS REPORT | |
| AU4407996A (en) | Neural network method and apparatus for disease, injury and bodily condition screening or sensing | |
| EP1049088A4 (en) | SYSTEM, DEVICE AND METHOD FOR PROCESSING INFORMATION | |
| EP1075219A4 (en) | APPARATUS AND METHOD FOR FACILITATING HEMOSTASIS ON A BIOPSY PATH | |
| EP1309902A4 (en) | SYSTEM AND METHOD FOR MONITORING AND CONTROLLING POWER DISTRIBUTION | |
| EP1366460A4 (en) | METHOD AND SYSTEM FOR DETECTION OF FECAL MATERIALS AND INGESTA DURING THE TREATMENT OF MEAT AND POULTRY | |
| EP0831924A4 (en) | METHOD FOR TREATING ASTHMA | |
| EP1007535A4 (en) | METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING BREAST CANCER | |
| FR2837053B1 (en) | METHOD AND SYSTEM FOR BI OR MULTI-ENERGETIC IMAGING | |
| EP1056346A4 (en) | METHOD AND SYSTEM FOR PILING ANIMALS | |
| EP1229834A4 (en) | SYSTEM AND METHOD FOR QUANTITATIVE AND QUALITATIVE HAND ANALYSIS | |
| FR2658617B1 (en) | DEVICE AND METHOD FOR IDENTIFYING AND QUANTIFYING HYDROMETEORES BY DOPPLER EFFECT. | |
| FR2792430B1 (en) | SYSTEM AND METHOD FOR MONITORING IMAGE FORMING APPARATUS | |
| EP1066408A4 (en) | NOVEL METHOD FOR DETECTION AND MONITORING OF ENDOMETRIAL OR UTERINE CANCER | |
| EP0986340A4 (en) | OPAQUE X-RAY SOLUTION FOR VISUALIZING DENTAL ANATOMY AND AREAS PRESENTING PATHOLOGICAL CONDITIONS AND IATROGENIC DISORDERS, AND METHOD OF USING THE SAME | |
| FR2835936B1 (en) | METHOD AND SYSTEM FOR ANALYZING SOFTWARE LOCKING EVENTS | |
| EP1001405A4 (en) | IMAGE PROCESSING METHOD AND IMAGE DISPLAY | |
| FR2774785B1 (en) | AN APPLICATION MANAGEMENT METHOD AND INFORMATION PROCESSING APPARATUS USING THE METHOD | |
| EP0805972A4 (en) | Method and apparatus for diagnosis, detection of cell abnormalities and morphology of living systems | |
| FR2765591B1 (en) | METHOD FOR DIAGNOSING ALZHEIMER'S DISEASE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20010305 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20020604 |
|
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7G 01N 33/574 A, 7C 07K 16/30 B, 7C 12Q 1/68 B, 7A 61K 39/395 B |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: DIADEXUS, INC. |
|
| 17Q | First examination report despatched |
Effective date: 20030630 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20050924 |